Stay updated on Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:45:00.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error message with a 403 header and a Home link, replacing the expected study record content.
    Difference
    0.5%
    Check dated 2026-09-27T17:56:14.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an access-denied notice. The deletions remove the previously visible study documents and details, indicating restricted access to the record.
    Difference
    21%
    Check dated 2026-09-20T11:27:06.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, indicating a newer revision of the study record page. It appears to be a metadata update rather than a change to study content or outcomes.
    Difference
    0.0%
    Check dated 2026-08-29T23:47:08.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page now shows a new revision tag, indicating a software release version has been updated from v3.6.4 to v3.6.5. This is a metadata update and does not change the study information presented on the page.
    Difference
    0.0%
    Check dated 2026-08-08T18:07:52.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a minor backend/template update. There is no indication of changes to study details or other user-facing content.
    Difference
    0.0%
    Check dated 2026-07-25T10:33:12.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.